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of 20 studies.[1b] The traditional treatment 
method, in over 90% of cases,[3] for MK 
is a broad spectrum of fortified antibiotic 
eye drops.[4] However, prolonged use of 
antibiotics is toxic to the cornea and can 
have a detrimental effect on corneal ree
pithelialization.[4b] There is also a lack 
of efficacy with the use of antibiotic eye 
drops with only approximately 5% being 
absorbed.[5] In addition, antimicrobial 
resistance has been identified by the 
World Health Organisation as a growing 
threat.[4a,6] In some cases, bandage con-
tact lenses are applied to aid wound 
healing and prevent further microbial 
insult during healing.[7] Therefore, there 
is potential in exploring a synthetic 
antimicrobial contact lens which could 
prevent bacterial adhesion when the epi-
thelium is compromised, such as during 
corneal collagen cross-linking, or be used 
as a tool in the treatment for MK.
Several antimicrobial peptides (AMPs) 
have been found in the ocular surface, such as defensins and 
LL-37.[8] The typical, although not exclusive, general mode 
of action of cationic peptides is disruption of the microbial 
membrane.[8,9] The cationic peptides interact with the anionic 
components of microbial membranes, causing disruption and 
permeabilization, leading to cell death.[8,10] The Willcox group at 
University of New South Wales (UNSW) is experienced in AMP 
modification of contact lenses. The group has reported pri-
marily on the AMP melimine and its shorter derivative, Mel4.[11] 
Melimine is a cationic AMP which has previously been shown to 
have a broad spectrum of antimicrobial activity however super-
ficial corneal staining was reported in a human trial.[11a,b,d,e,h] 
Mel4 is a smaller derivative of melimine, which had less cor-
neal staining compared to melimine lenses.[11d] Contact lenses 
modified with Mel4 at a concentration of 3.1 mg cm−3 have been 
reported to be active against many bacterial strains with no tox-
icity or ocular irritation in an animal study.[11c,f,g]
Poly-ε-lysine (PεK) is a naturally occurring AMP that is non-
toxic and used as both an emulsifier and food preservative.[7,12] 
The Williams group of the University of Liverpool (UoL) can 
produce a family of hydrogels synthesized from pεK peptide, 
cross-linked with bis-carboxylic acids to produce tailorable, 
transparent hydrogels that are nontoxic to corneal cells in vitro. 
They have demonstrated the antimicrobial properties of these 
hydrogels against S. aureus and they can be cast into contact 
lens molds.[3,7,13] Free amine groups are present on the hydrogel 
surface allowing the covalent binding of additional AMPs. In 
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Microbial keratitis (MK) is an infectious disease affecting the 
cornea leading to inflammation, ulcerations, and eventually 
vision loss. MK is a severe public health problem and equates 
to 1.5–2 million cases of vision loss annually.[1] Bacterial kera-
titis is the most common form of keratitis in developed coun-
tries, usually arising from contact lens wear.[1a,2] Pseudomonas 
aeruginosa (P. aeruginosa) is one of the top three isolates in 13 
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this study, we aim to combine our expertise and investigate the 
antimicrobial activity of two promising AMPs, pεK and Mel4, 
covalently bound to a hydrogel contact lens, against P. aerugi-
nosa for the prevention and treatment of MK.
PεK was cross-linked 60% with octanedioic-acid using 
N-hydroxysulfosuccinimide (NHS) and 1-ethyl-3-(3-dimethyl-
aminopropyl) carbodiimide (EDCI), to a polymer density of 
either 0.1 or 0.13 g cm−3 (named 60%0.1 and 60%0.13, respec-
tively, hereafter) as previously described, see Table S1 (Sup-
porting Information).[7] The physical properties of the hydrogels 
including their contact angle, water content, tensile properties, 
and transparency were investigated. Both hydrogels were highly 
hydrophilic and had an average contact angle of 15.1° ± 4° and 
16.3°  ±  5.6 for 60%0.1 and 60%0.13 respectively; hydrogels 
were not significantly different (p = 0.775) (Figure 1a), meaning 
water spread easily across the surface. High wettability of con-
tact lenses has been linked to better comfort.[14] The hydro-
philic nature of the pεK hydrogels is likely due to the presence 
of many polar amine groups on the materials surface, as well 
the high water content of hydrogels. Both pεK hydrogels had 
a high water content similar to commercially available contact 
lenses,[15] 71.8% ± 1.5 and 68.5% ± 5.8 for 60%0.1 and 60%0.13, 
respectively (p  = 0.38; Figure  1b). Water in the hydrogel can 
facilitate oxygen permeability and transport; which may help 
prevent corneal edema.[14a] The elastic moduli of both hydrogels 
was similar; 60%1.3 was stiffer at 402.4 kPa ± 72.1 compared to 
256.8 kPa ± 45.9 for 60%0.1 (p = 0.078) (Figure 1c). The ultimate 
tensile strength (UTS) was significantly different (p  = 0.021); 
60%0.1 had a UTS of 45.9 kPa whereas 60%0.13 was higher at 
72.1 kPa (Figure 1c). However, 60%0.1 was easier to handle and 
less prone to snapping when pinched. These values are within 
the range of soft hydrogels, especially the Acuvue lens product 
family.[15] Previous work on these hydrogels indicated there was 
a slight increase in stiffness, but an insignificant change in UTS 
following covalent attachment of additional pεK.[7] Both hydro-
gels had excellent transparency, allowing passage of light across 
all the tested wavelengths of the visible spectrum; 560 nm 
was chosen as a representative wavelength. The % light trans-
mission was 94.4%  ± 0.7 and 93.1%  ± 0.2 for 60%0.1 and 
60%0.13, respectively (Figure  1d). Light transmission for other 
wavelengths can be found in Figure S1 (Supporting Informa-
tion). These were comparable to a control commercial contact 
lens (Acuvue 2) at 98.2% ± 0.8, however both hydrogels were 
significantly different to the control (p < 0.001). These physical 
properties of the hydrogels demonstrate their suitability and 
potential to be used as a therapeutic contact lens.
To demonstrate whether additional peptides successfully 
bound to the hydrogels, pεK and Mel4 were fluorescently 
tagged with Alexa Fluor 594 NHS ester (named +pεK 594 and 
+Mel4 594), prior to covalently binding them to pεK hydrogels. 
Untagged peptides (+pεK and +Mel4) served as controls. Covalent 
binding of untagged peptides caused no change in fluorescence 
compared to bare gel (60%0.1). Hydrogels with fluorescently 
tagged peptides had approximately 12-fold increase in fluorescent 
signals, despite copious washes with water; confirming the pep-
tides were covalently bound to the hydrogels (Figure 1e). Due to 
the strong fluorescent signal, the widely reported carbodiimide 
chemistry methods, and the observed antimicrobial activity, we 
did not repeat this experiment for statistical analysis.
Lenses were incubated with 1 × 106 CFU P. aeruginosa over-
night and the number which had bound to the lenses were 
determined. The polymer density in the hydrogel had an insig-
nificant effect on bacterial adhesion, irrespective of subsequent 
peptide modification. The bare pεK hydrogels had a small log 
reduction of 0.6 (60%0.1) and 0.7 (60%0.13) compared to inoc-
ulum (Figure 2). PεK is innately antimicrobial due to its cati-
onic nature but nine or more free lysine residues are required 
for optimal antimicrobial activity.[16] This is likely the reason 
why bare pεK hydrogels are not inherently antimicrobial, due 
to their cross-linked nature they do not have many molecular 
chains long enough to disrupt bacterial membranes.
These hydrogels, however, have an abundance of free amine 
groups which can be further used to covalently bind cell adhe-
sive motifs,[13a] ionically trap antimicrobial drugs, or covalently 
bind AMPs.[7,13b] The UoL group has previously demonstrated 
that we can impart antimicrobial activity by binding additional 
pεK peptides to the surface of the hydrogels using a similar 
method to the hydrogel synthesis but in the absence of a cross-
linking diacid. This method was effective at producing an 
≈2 log reduction in attached Staphylococcus aureus compared to 
the bare gel. A similar reduction in planktonic S. aureus was 
observed when hydrogels were impregnated with penicillin G.[7] 
Here, we demonstrate that when additional pεK was bound to 
both hydrogels (60%0.1 + pεK and 60%0.13 + pεK) there was 
a >3  log reduction in CFU for P. aeruginosa compared to the 
inoculum (Figure 2). These were significantly different to bare 
lenses (p < 0.05).
The addition of Mel4 resulted in a 0.2 log reduction com-
pared to inoculum on 60%0.1 + Mel4 hydrogels (p = 0.0085 and 
0.011 compared to 60%0.1 + pεK, and 60%0.13 + pεK, respec-
tively), and less on the 60%0.13 + Mel4 (p = 0.0066 and 0.0085 
compared to 60%0.1 + pεK, and 60%0.13 + pεK, respectively). 
Addition of Mel4, using the same binding method to that used 
for pεK, on the commercial polyhydroxyethyl methacrylate 
(pHEMA) contact lenses (Acuvue 2, Etafilcon A) resulted in a 
0.5 log reduction in CFU. Previous work by the Willcox group 
has demonstrated a >2  log reduction against P. aeruginosa 
when Mel4 bound was bound to silicone hydrogel lenses[11g] 
and a 1.3 log reduction when bound to pHEMA.[11f ] In these 
studies a different method of binding the Mel4 was used which 
would influence the way in which the AMP was attached to the 
surface. When pεK was bound to commercial pHEMA lenses a 
lesser effect (1.2 log reduction) was observed compared to the 
60%0.1 + pεK and 60%0.13 + pεK hydrogel equivalents, this 
was not significantly different compared to any lenses (p > 0.05, 
Figure 2).
There are two main considerations which may explain why 
we observe differences in this and earlier studies. The first con-
sideration is the difference in peptide binding methods due to 
the different surface chemistry of pεK hydrogels and pHEMA. 
The pHEMA or acrylic acid-modified silicone lenses contain 
surface carboxyl groups whereas the pεK hydrogels contain 
surface amine groups. The EDCI/NHS reacts with the car-
boxyl groups and promotes the peptide bond formation with 
the amine functional groups.[17] The amine rich pεK hydrogel 
surface encourages the carboxyl of the peptide C-terminus to 
bind to the surface, whereas any amine along the pεK peptide 
may bind to the “activated” carboxyl groups of the pHEMA, 
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Figure 1. Physical properties of 60%0.1 and 60%0.13 pεK hydrogels demonstrated; a) Hydrogels were very hydrophilic (15.1° – 16.3°). b) Hydrogels had 
a high water content (63.7 – 67.8%). c). The pεK hydrogels stiffness ranged between 256.8 and 402.4 kPa and ultimate tensile strength (UTS) ranged 
between 45.9 and 72.1, which was significantly different to each other, p = 0.021. d) Hydrogels were extremely transparent (93.1–94.4%), however, both 
hydrogels were significantly different to the control (98.2%), p < 0.001. 560 nm shown as representative wavelength. e) Hydrogels bound with fluores-
cently tagged peptides had a high relative fluorescence signal (12-fold increase) even after extensive washing, confirming covalent binding. Error bars 
represent ±1 standard deviation. *p < 0.05, ***p < 0.001.
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thereby shortening the AMP chain length. This could influence 
the antimicrobial activity of the bound AMP, resulting in the 
significant reduction in antimicrobial activity observed when 
pεK was bound to pHEMA lenses compared to pεK hydrogels 
(Figure 2). However, previous work by UNSW has shown that 
the activity of melimine is reduced when bound to a surface 
by its C-terminus compared to when bound by its N-terminus 
or at an approximate central position.[18] This may explain the 
reduction of antimicrobial activity of Mel4 compared to pre-
vious work. This work may indicate that aminated surfaces are 
beneficial for modification by some AMPs, but not others and 
so the optimal binding method should be considered for each 
AMP.
The second consideration is the difference in length of the 
peptides; pεK used in this study contains approximately 25–35 
residues, whereas the Mel4 contains only 17 residues, which 
may explain the differences in antimicrobial activity between 
pεK and Mel4 observed in this study. Liu et al. also showed that 
increasing the length of AMPs improved their antimicrobial 
activity by synthesizing repeated units of Arg(R) and Trp(W), 
RWn where n = 1–5,[19] and the longer peptide melimine (29 res-
idues) has greater antimicrobial activity compared to the shorter 
Mel4.[11f ] Researchers from UNSW “activated” the surface car-
boxyl groups on the acrylics prior to adding AMPs[11c-h] whereas 
within this and previous studies from UoL researchers[7,13a] 
AMPs and EDCI/NHS are added simultaneously. Adding 
AMP and EDCI/NHS simultaneously could cause some AMPs 
to bind to each other, effectively shortening the chain of free 
amino acids, creating an interconnected net-like structure, 
which may reduce the antimicrobial effect although the mecha-
nisms are likely to be more complicated for AMPs which have 
a variety of amino acids compared to the simple pεK.[9a] For 
example work by Juba et al. demonstrated differences in efficacy 
and mechanism between the AMP peptide NA-CATH and its 
truncated isomers l- and d-ATRA-1A; NA-CATH had a greater 
antimicrobial activity.[20] These different binding methods 
could also explain the reduced efficacy of Mel4 when bound to 
pHEMA in this work compared to previous publications. Mel4 
was added at the same concentration as the previously reported 
work. The binding method reported in this work is expected to 
behave similarly.
For the ex vivo study only 60%0.1 pεK hydrogels were used 
as they had favorable handling properties with no difference 
in antibacterial properties between the two formulations. We 
adapted an ex vivo culture model,[21] and damaged the cornea by 
ethanol treatment and mechanical scraping then pipetted the 
bacteria onto the cornea. This successfully removed the super-
ficial stratified epithelium (Figure 3b) which contains the glyco-
calyx and successfully allowed an inoculum of 106 P. aeruginosa 
6294 to infect and disrupt the remaining epithelium.[22] Prior 
to wounding, the porcine corneas had 2–3 layers superficial 
stratified squamous epithelium, observed as densely stained 
areas (Figure  3a), similar to that reported by Crespo-Morales 
et  al.[23] Corneas incubated overnight without inoculation 
with P. aeruginosa had begun to regrow a squamous epithelial 
layer (Figure  3b−g). Removal of the superficial layers allowed 
P. aeruginosa to infect the corneas where no hydrogels were 
present, which resulted in disintegration of the epithelium. 
During overnight incubation the epithelium became compro-
mised and dissociated from the stroma (Figure 3c) and a high 
density of Gram-stained bacteria was observed on the exposed 
stroma (Figure 3h).
The H&E and Gram staining demonstrated that if a hydrogel 
(60%0.1, 60%0.1 + pεK or 60%0.1 + Mel4) was placed on the 
cornea after inoculation the epithelium beneath the hydrogels 
was preserved and remained largely intact (Figure 3d−f), com-
pared to infection control samples with no hydrogel (Figure 3c). 
Although some bacteria were observed on the apical surface 
of the epithelium, there were no bacteria observed within the 
epithelium or the stroma beneath these hydrogels suggesting 
that direct contact of the AMPs killed the bacteria before they 
were able to invade the stromal tissue, similar to a recently 
published study.[24] These lenses may be useful as a bandage 
contact lens following corneal collagen cross-linking to prevent 
microbial keratitis, as current bandage lenses have been identi-
fied as a possible risk factor.[25] Many bacteria were observed on 
the apical surface beneath bare 60%0.1 hydrogels (Figure  3i), 
whereas only a few bacteria were observed beneath +pεK 
(Figure 3k) or +Mel4 hydrogels (Figure 3m). Gram stained bac-
teria were present at the outer edges of the corneas which were 
not beneath the hydrogels and the epithelium appeared similar 
to the infection control (Figure  3j,l,m). This suggests that the 
AMPs were covalently bound to the hydrogels as antimicrobial 
action was only observed when in contact with the infected 
area. A dual action lens could be developed with pεK bound to 
hydrogel which was soaked in an antimicrobial agent that could 
elute over time to add further functionality to these lenses.[7,13b]
We have demonstrated that a pεK-based hydrogel can impart 
antimicrobial activity in vitro and in a porcine ex vivo model 
against a clinical isolate of P. aeruginosa. A >3.0  log reduction 
can be achieved when additional pεK is bound to the surface 
Figure 2. Log reduction of bacteria compared to inoculum on novel 
hydrogels and commercial lenses (Acuvue2) with bound antimicrobial 
peptides. The addition of pendant pεK resulted in the greatest reduc-
tion across all lens types. A >3  log reduction was observed on pεK + 
pεK hydrogels. Both pεK + pεK hydrogels were significantly different 
to 60%0.13 + Mel4 and Commercial Lens + Mel4 by p < 0.01, and bare 
60%0.1 and 60%0.13 hydrogels by p  < 0.05. 60%0.1 + Mel4 was also 
significantly different to 60%0.1 + pεK (p  < 0.01) and 60%0.13 + pεK 
(p < 0.05). *p < 0.05, **p < 0.01.
Adv. Mater. Interfaces 2020, 2001232
www.advancedsciencenews.com
www.advmatinterfaces.de
2001232 (5 of 6) © 2020 The Authors. Published by Wiley-VCH GmbH
Figure 3. a−f) H&E and g−n) gram staining of formalin-fixed paraffin-embedded porcine corneas. a) Nonwounded no infection control shows the 
intact porcine cornea; b) wounded no infection control demonstrates removal of apical stratified squamous layers by wounding; c) infection control 
demonstrates destruction of the cornea after 18 h incubation with P. aeruginosa; d) 60%0.1 hydrogel demonstrates preservation of the epithelium 
despite P. aeruginosa; e) shows epithelial preservation by 60%0.1 + pεK hydrogel; f) similarly demonstrates epithelial preservation by 60%0.1 + Mel4 
hydrogel; g) no infection control demonstrating stratified epithelium and one layer of regrowth of the apical squamous epithelium; h) demonstrates 
complete removal of the epithelium and bacterial penetration into the stroma tissue 18 h after inoculation with P. aeruginosa 6294; i) demonstrates 
the area beneath 60%0.1 hydrogel, showing many bacteria near the detached epithelial cells; j) shows the edge of the same in an area not underneath 
the hydrogel; k) demonstrates an intact epithelium beneath a 60%0.1 + pεK hydrogel with very few bacteria present; l) represents an area of the same 
cornea not beneath the hydrogel; m) also demonstrates perseveration of the corneal epithelium beneath a 60%0.1 + Mel4 hydrogel with only a few 
bacteria visible on the apical surface; n) demonstrates a compromised epithelium in an area not beneath the 60%0.1 + Mel4 hydrogel. Black arrows 
indicate P. aeruginosa. Scale bar = 10 µm
Adv. Mater. Interfaces 2020, 2001232
www.advancedsciencenews.com
www.advmatinterfaces.de
2001232 (6 of 6) © 2020 The Authors. Published by Wiley-VCH GmbH
of the hydrogel. Mel4 does not effectively impart antimicrobial 
activity when bound to the pεK surface or the pHEMA surface 
using this binding technique. Ex vivo analysis demonstrated 
that hydrogels preserved the epithelium after 18 h of incubation 
with P. aeruginosa 6294 and demonstrated positive antimicro-
bial activity when hydrogels were bound with additional AMPs 
(+pεK and +Mel4) in the area underneath the gels suggesting 
that direct contact with the bound AMPs is necessary to kill the 
bacteria.
Experimental Section
See supporting information. The data used in publication can be found 
at https://doi.org/10.17638/datacat.liverpool.ac.uk/1149. The porcine 
corneas for the ex vivo model were obtained as a waste product from the 
meat industry, and did not require ethical approval.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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